a public good project by the
Synthesis
Company
of California

© 2026

F Mughal | doi.page

0 works0 citations0 h-index

F Mughal

Churchill Hospital(GB)Daiichi Sankyo (United Kingdom)(GB)St Clement's Hospital(GB)

Publications by Year

Research Areas

Health Systems, Economic Evaluations, Quality of Life, Psoriasis: Treatment and Pathogenesis, Atrial Fibrillation Management and Outcomes, Pharmaceutical studies and practices, Rheumatoid Arthritis Research and Therapies

Most-Cited Works

→ Comparing preferences for outcomes of psoriasis treatments among patients and dermatologists in the U.K.: results from a discrete-choice experiment(2016)30 cited
→ Evaluation of psoriasis patients&rsquo; attitudes toward benefit&ndash;risk and therapeutic trade-offs in their choice of treatments(2017)22 cited
→ Evaluation of the Economic Burden of Psoriatic Arthritis and the Relationship Between Functional Status and Healthcare Costs(2019)18 cited
→ Direct Oral Anticoagulant (DOAC) Dosing in Patients with Non-valvular Atrial Fibrillation (NVAF) in the United Kingdom: A Retrospective Cohort Study Using CPRD Gold Database(2022)10 cited
→ Cost-effectiveness of apremilast in moderate to severe psoriasis in the United Kingdom(2018)5 cited
→ Cost-Effectiveness of Apremilast In Moderate to Severe Psoriasis In Scotland(2015)3 cited

→ Cost-Effectiveness of Apremilast In Psoriatic Arthritis In Scotland(2015)

2 cited

→ Budget Impact of Apremilast For Active Psoriatic Arthritis In The UK(2016)1 cited

→ POSA322 Applying Machine Learning to Identify Predictors of Major Bleeding Among Patients with Atrial Fibrillation Who Initialized Oral Anticoagulants in the Clinical Practice Research Datalink and Hospital Episode Statistics(2022)1 cited

→ Challenges for decision-makers when assessing within-class comparative effectiveness: the case of anticoagulation therapy for atrial fibrillation(2022)1 cited